FABP7 has been implicated multiple cancers, Down syndrome, schizophrenia, and various neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD), and Alzheimer’s disease (AD) (Cheon et al., 2003; Sánchez-Font et al., 2003; Watanabe et al., 2007; Teunissen et al., 2011; Guttula et al., 2012; Matsumata et al., 2016; Kagawa et al., 2019; Killoy et al., 2020; Young, 2020; Asaro et al., 2021; Koga et al., 2021; Cheng et al., 2022; Needham et al., 2022; Tandon et al., 2023). This evidence concerns the gene FABP7 and amyotrophic lateral sclerosis.